ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,621.42
1.16%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) Noticias

THTX Theratechnologies Inc

1.28
-0.06 (-4.48%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Theratechnologies Inc THTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.06 -4.48% 1.28 23:00:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.31 1.27 1.32 1.28 1.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
15/4/202415:15GLOBETheratechnologies Announces Mailing of Management Proxy..
11/4/202406:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
10/4/202406:30GLOBETheratechnologies Reports Financial Results and Provides..
10/4/202406:15IHMARKETNEWSU.S. Index Futures Show Mixed Trend Ahead of Key Inflation..
08/4/202415:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
05/4/202410:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
03/4/202406:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
28/3/202406:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
22/3/202408:36GLOBETheratechnologies Announces Update on its Preclinical..
21/3/202419:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
21/3/202406:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
29/2/202415:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202415:34GLOBETheratechnologies Announces the Resignation of One of Its..
27/2/202407:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202406:30GLOBETheratechnologies Receives Refusal to File Letter for..
21/2/202407:01EDGAR2Form 20-F - Annual and transition report of foreign private..
21/2/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202406:30GLOBETheratechnologies Reports Financial Results for the Fourth..
20/2/202406:30GLOBETheratechnologies Announces Publication in Frontiers in..
15/2/202407:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202406:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
06/2/202413:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/2/202406:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
01/2/202410:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202412:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202406:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
23/1/202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202406:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
03/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
02/1/202415:28EDGAR2Form F-3/A - Registration statement by foreign private..
02/1/202408:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
02/1/202406:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
21/12/202315:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202315:12PRNCATheratechnologies annonce le renouvellement de son..
21/12/202315:09PRNCATheratechnologies Announces Renewal of Shelf Prospectus and..
21/12/202312:21EDGAR2Form F-3 - Registration statement by foreign private issuers
13/12/202313:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202306:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
28/11/202315:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
24/11/202306:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
06/11/202312:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202311:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202313:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202311:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202311:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
26/10/202320:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202308:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202307:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
25/10/202315:13GLOBETheratechnologies Announces Proposed Public Offering of..

Su Consulta Reciente

NASDAQ
THTX
Theratechnologies
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados